摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(1S,2R,3S,5S)-2-(3-aminobicyclo<3.1.0>hex-2-yl)ethanol | 219707-84-3

中文名称
——
中文别名
——
英文名称
(1S,2R,3S,5S)-2-(3-aminobicyclo<3.1.0>hex-2-yl)ethanol
英文别名
2-[(1S,2S,3S,5S)-3-amino-2-bicyclo[3.1.0]hexanyl]ethanol
(1S,2R,3S,5S)-2-(3-aminobicyclo<3.1.0>hex-2-yl)ethanol化学式
CAS
219707-84-3
化学式
C8H15NO
mdl
——
分子量
141.213
InChiKey
XEGYBEBZYYLRCP-XAMCCFCMSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    238.288±13.00 °C(Press: 760.00 Torr)(predicted)
  • 密度:
    1.085±0.06 g/cm3(Temp: 25 °C; Press: 760 Torr)(predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    0.2
  • 重原子数:
    10
  • 可旋转键数:
    2
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    1.0
  • 拓扑面积:
    46.2
  • 氢给体数:
    2
  • 氢受体数:
    2

反应信息

  • 作为反应物:
    描述:
    (1S,2R,3S,5S)-2-(3-aminobicyclo<3.1.0>hex-2-yl)ethanol盐酸三乙胺 、 tin(ll) chloride 作用下, 以 乙醇二氯甲烷 为溶剂, 反应 9.5h, 生成 (1S,2R,3S,5S)-2-<3-(6-chloro-purin-9-yl)bicyclo<3.1.0>hex-2-yl>ethanol
    参考文献:
    名称:
    Enantiomeric synthesis of nucleosides
    摘要:
    The total synthesis of L- (or 1S,2R,3S,5S)-bicarbocyclic nucleosides (8-15) has been accomplished. The key intermediate 3 was synthesized in two steps from the known chiral compound 1 through a stereoselective cyclopropanation under Furukawa conditions and its X-ray structure has been determined. The derivative 4 was utilized to obtain thymine derivative (8). Amine exocyclic pyrimidine (9-12) and purine (13-15) bicarbocyclic L-nucleosides were obtained from the (IS,2R,3S,5S)-2-(3-aminobicyclo[3.1.0]hex-2-yl)ethanol (7). (C) 1999 Elsevier Science Ltd. All rights reserved.
    DOI:
    10.1016/s0040-4020(99)00424-x
  • 作为产物:
    描述:
    (1S,2R,3R,5S)-2-(3-hydroxybicyclo<3.1.0>hex-2-yl)ethanol tert-butyldimethylsilane ether 在 palladium on activated charcoal 吡啶 、 sodium azide 、 氢气 作用下, 以 甲醇N,N-二甲基甲酰胺 为溶剂, 生成 (1S,2R,3S,5S)-2-(3-aminobicyclo<3.1.0>hex-2-yl)ethanol
    参考文献:
    名称:
    立体选择性合成α-1-二碳环核苷作为潜在的抗病毒药物
    摘要:
    描述了迄今未知的碳环α-L-异构双环[3.1.0]己基核苷(8-11)的合成。在古河条件下,通过立体选择性环丙烷化,由已知的手性化合物1分七个步骤合成了关键中间体7。在HepG2T14细胞中,化合物8-11被评估为抗HBV药物。
    DOI:
    10.1016/s0040-4039(98)02137-6
点击查看最新优质反应信息

文献信息

  • Stereoselective synthesis of α-l-bicarbocyclic nucleosides as potential antiviral drugs
    作者:Christine Demaison、Christophe Hourioux、Philippe Roingeard、Luigi A. Agrofoglio
    DOI:10.1016/s0040-4039(98)02137-6
    日期:1998.12
    Synthesis of hitherto unknown carbocyclic α-L-isomeric bicyclo[3.1.0]hexyl nucleosides (8–11) is described. The key intermediate 7 was synthesized in seven steps from the known chiral compound 1 through a stereoselective cyclopropanation under Furukawa conditions. Compounds 8–11 were evaluated as anti-HBV agents in HepG2T14 cells.
    描述了迄今未知的碳环α-L-异构双环[3.1.0]己基核苷(8-11)的合成。在古河条件下,通过立体选择性环丙烷化,由已知的手性化合物1分七个步骤合成了关键中间体7。在HepG2T14细胞中,化合物8-11被评估为抗HBV药物。
  • Stereoselective Synthesis of Carbocyclic α-L-Homonucleosides
    作者:L. A. Agrofoglio、F. Girard、C. Demaison、M-G. Lee、P. Roingeard、A. Fridland
    DOI:10.1080/15257779908041509
    日期:1999.4
    The synthesis of several optically pure carbocyclic alpha-1-isomeric homonucleosides [3a-e, 6a,b, 7a,b, 10a-d] is reported. The(1R, 5S)-2-oxabicyclo[3.3.0] oct-6-en-3-one 1 was used as a chiral starting material.
  • Enantiomeric synthesis of nucleosides
    作者:Luigi A. Agrofoglio、Christine Demaison、Loïc Toupet
    DOI:10.1016/s0040-4020(99)00424-x
    日期:1999.6
    The total synthesis of L- (or 1S,2R,3S,5S)-bicarbocyclic nucleosides (8-15) has been accomplished. The key intermediate 3 was synthesized in two steps from the known chiral compound 1 through a stereoselective cyclopropanation under Furukawa conditions and its X-ray structure has been determined. The derivative 4 was utilized to obtain thymine derivative (8). Amine exocyclic pyrimidine (9-12) and purine (13-15) bicarbocyclic L-nucleosides were obtained from the (IS,2R,3S,5S)-2-(3-aminobicyclo[3.1.0]hex-2-yl)ethanol (7). (C) 1999 Elsevier Science Ltd. All rights reserved.
查看更多